The definition of HER2-low breast cancer, typically characterized as HER2 1+ or HER2 2+ without FISH amplification, is not universally agreed upon; however, these tumors are currently classified as HER2-negative breast cancer. Here, ERBB2 is linked to breast carcinoma.